Lung cancer screening eligibility generally means being age 50 to 80, having at least a 20 pack-year smoking history, and currently smoking or having quit within 15 years. Those are the 2021 USPSTF criteria for annual low-dose CT. Medicare has similar rules but stops coverage at age 77 and requires an order plus an initial counseling visit.
1. Lung cancer screening eligibility starts with age and smoking history
The U.S. Preventive Services Task Force, or USPSTF, recommends annual screening for adults ages 50 through 80 who have accumulated at least 20 pack-years of smoking. You must currently smoke or have quit within the previous 15 years.
The recommendation applies to people without signs or symptoms of lung cancer. Screening aims to find disease before symptoms appear; a scan ordered to investigate coughing up blood, unexplained weight loss, chest pain, or a persistent cough is diagnostic care, not routine screening.
Screening should stop once you have gone 15 years without smoking. It should also stop if a health condition substantially limits your life expectancy or means you couldn’t or wouldn’t undergo surgery intended to cure an early cancer. That last condition is sometimes overlooked: finding a small tumor is less likely to help if treatment isn’t medically feasible.
| Criterion | USPSTF 2021 | Medicare 2022 coverage criteria |
|---|---|---|
| Age | 50–80 years | 50–77 years |
| Smoking history | At least 20 pack-years | At least 20 pack-years |
| Smoking status | Current smoker or quit within 15 years | Current smoker or quit within 15 years |
| Symptoms | No signs or symptoms of lung cancer | Asymptomatic |
| Test and interval | Annual low-dose CT | Annual low-dose CT |
| Additional condition | Stop if curative surgery isn’t feasible | LDCT order; initial counseling visit required |
These thresholds aren’t a prediction that you have cancer. They identify a group in whom clinical trials found that the benefits of screening can outweigh harms. For context, screening ages and intervals differ by cancer type because each recommendation rests on different evidence.
2. Calculate your pack-years carefully
One pack-year means smoking 20 cigarettes, or one standard pack, each day for one year. Multiply the average number of packs smoked per day by the number of years you smoked: packs per day × years = pack-years.
For example, one pack daily for 20 years equals 20 pack-years. Two packs daily for 10 years also equals 20. Half a pack daily for 30 years equals 15 pack-years, so it doesn’t meet the USPSTF threshold even though the smoking history spans three decades.
Real histories can be messy. If your smoking changed, calculate each period separately: half a pack daily for 10 years is 5 pack-years, followed by one pack daily for 15 years, or 15 pack-years, for a total of 20. Tell your clinician if the estimate is uncertain rather than rounding aggressively to qualify.
Cigars, pipes, vaping, radon exposure, family history, and occupational hazards can affect lung-cancer risk, but they don’t replace the cigarette pack-year requirement in the 2021 USPSTF criteria. You can read more about how multiple exposures fit into cancer risk and prevention.
3. The recommended test is low-dose CT, not a chest X-ray
Low-dose computed tomography, or LDCT, uses X-rays and computer processing to produce cross-sectional images of your lungs. The detail is greater than a standard chest X-ray, which isn’t the recommended screening test.
An LDCT scan is quick and doesn’t usually require injected contrast. If a nodule appears, its size and features help determine whether you return for another scan, need earlier imaging, or should be evaluated further. Many lung nodules are not cancer.
Meeting lung cancer screening eligibility doesn’t mean every scan will be useful forever. The decision should account for your overall health, treatment preferences, and willingness to complete follow-up. Medicare therefore requires counseling and shared decision-making before the first covered scan, as well as an LDCT order.
4. False positives are common, but practices have improved
A positive screening result is not the same as a cancer diagnosis. In the National Lung Screening Trial, false-positive rates were 26.3% at the baseline scan, 27.2% in year one, and 15.9% in year two. Most were managed with imaging, although some led to invasive procedures.
The 2021 USPSTF evidence review found that 0.09% to 0.56% of all screened participants underwent a needle biopsy because of a false-positive result. Those percentages are small, but the consequences can include anxiety, complications, additional radiation, and cost.
How results are classified matters. In a retrospective analysis cited by the USPSTF, applying the Lung-RADS reporting system to baseline trial scans reduced the false-positive rate from 26.6% to 12.8%. Because researchers reclassified earlier scans rather than testing the system prospectively in that trial, the comparison shouldn’t be read as a guarantee of what any clinic will achieve.
Honestly, screening is valuable for the right group, but it’s not harmless reassurance. Before agreeing, ask how the center manages small nodules and whether it uses a standardized reporting system.
5. Radiation is low, not zero
A low-dose lung CT delivers an estimated 1.5 millisieverts, or mSv, of radiation. Average natural-background exposure in the United States is about 3 mSv per year, making one scan roughly comparable to six months of everyday background exposure.
The comparison provides scale, not proof that repeated scans carry no risk. Radiation exposure accumulates, and annual screening may continue for years. Even so, the dose is lower than that of a conventional diagnostic chest CT, and the USPSTF concluded that annual LDCT offers a net benefit for people who meet its criteria.
Don’t substitute another scan or a chest X-ray because it sounds simpler. Lung cancer screening eligibility is tied to LDCT because that’s the method evaluated in the evidence behind the recommendation.
6. Check coverage, then act on risks screening can’t remove
Medicare Part B covers annual LDCT for eligible beneficiaries ages 50 to 77 who are asymptomatic, meet the smoking-history rules, and have an order. An initial counseling and shared-decision-making visit is required. Confirm the imaging center’s Medicare status and your current benefits before the appointment.
Most Marketplace plans and other non-grandfathered private plans must cover USPSTF preventive services rated A or B without cost-sharing when federal coverage requirements apply. HealthCare.gov warns that no-cost preventive coverage generally depends on using an in-network provider, and plan rules can differ. If approval stalls, this guide to prior authorization and treatment delays explains the paperwork and appeal process.
Uptake remains strikingly low. The 2026 Annual Report to the Nation reported that 18.7% of eligible U.S. adults were up to date in 2024, compared with 4.5% in 2015. Those are reported screening rates, not evidence that every unscreened person refused care; access, awareness, insurance, and clinician referral can all affect participation.
Screening doesn’t prevent lung cancer. Quitting smoking remains the most important action if you smoke, and CDC guidance updated in 2026 confirms that risk declines after quitting. Smoking also affects cardiovascular health, discussed in this overview of the connection between lung and heart health.
Radon deserves attention too. The CDC identifies it as the second-leading cause of lung-cancer deaths in the United States after cigarette smoke and estimates that it contributes to more than 21,000 deaths annually. Radon exposure alone doesn’t establish eligibility under USPSTF rules, but home testing can identify a preventable exposure.
If you may qualify, a practical sequence is:
- Calculate your pack-years and record when you quit, if applicable.
- Ask a qualified clinician whether screening fits your health and treatment preferences, especially if you have symptoms, serious chronic illness, or prior cancer care.
- Confirm that the LDCT facility and ordering clinician are in network.
- Ask how and when results will arrive and who will coordinate follow-up.
- If you smoke, request evidence-based help with quitting regardless of whether you choose screening.
Frequently asked questions
Who is eligible for lung cancer screening?
Under the 2021 USPSTF recommendation, eligibility generally covers adults ages 50 to 80 with at least 20 pack-years who currently smoke or quit within 15 years. Screening is intended for people without lung-cancer symptoms.
Can I get screened if I quit smoking more than 15 years ago?
You fall outside the USPSTF recommendation once more than 15 years have passed since quitting. A clinician can still assess symptoms and individual risk, but that evaluation isn’t the same as guideline-based annual screening.
Does Medicare cover lung cancer screening every year?
Medicare Part B covers annual LDCT for qualifying beneficiaries ages 50 to 77, subject to its smoking-history, symptom, order, and counseling requirements. Verify current coverage before scheduling because network and billing details can affect your costs.
Can nonsmokers qualify for lung cancer screening?
People without the required cigarette-smoking history don’t meet the 2021 USPSTF criteria, even if they have radon or workplace exposure. New symptoms still require medical evaluation rather than screening.
Is a chest X-ray enough for lung cancer screening?
No. The recommended test for eligible adults is annual low-dose CT, not a standard chest X-ray.